Liquidia (LQDA): Rentabilitas dodolan miturut bathi resik

Lambang korporat lan logo Liquidia Technologies (LQDA)

Liquidia Corporation (LQDA) cash flows are unstable due to patent litigation. High dependence on external manufacturers impacts the realization margin ratio, which the GURU.Markets platform captures in this chart; the parameter has stabilized at -15.20. Business prospects rely on the launch of Yutrepia and the development of unique drug delivery systems.

Liquidia Inc. (LQDA) - Margin dodolan perusahaan saka 04.07.2022 nganti 20.11.2026

Ringkesan rincian data analitis Liquidia Technologies (LQDA)

- nilai pasar lan prakiraan target analis:
Analisis wiwitan perusahaan:Liquidia, LQDA
Barang unggulan Liquidia Corp

Demand for Liquidia Corporation (LQDA) specialized drugs is inelastic; therefore, the core operating net margin reflects operational cost management efficiency rather than market conditions. This indicator measures the portion of net profit in every dollar of revenue, where stable values confirm the business model's resilience to costs, while a sharp decline signals a risk of capital impairment.

Karo sapa Liquidia Corporation saingan

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Galapagos N.V. - Margin dodolan resik|ANIP - Margin dodolan resik|MNKD: Margin dodolan resik|amphastar.com (AMPH) - Margin dodolan resik|PCRX (Pacira Pharmaceuticals) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ARS Pharmaceuticals, Inc. (SPRY)|Margin dodolan resik TBPH|AQST (Aquestive Therapeutics) - Tingkat bathi resik|scPharmaceuticals, Inc. - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik TECX|tonixpharma.com - Margin dodolan resik|Tingkat bathi resik SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Margin resik|Rentabilitas dodolan miturut bathi resik BioHarvest|Rentabilitas dodolan miturut bathi resik EXOZ|Rentabilitas dodolan miturut bathi resik Oramed Pharmaceuticals (ORMP)|Rentabilitas dodolan miturut bathi resik ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rentabilitas dodolan resik|Margin dodolan resik ABVC (ABVC BioPharma Inc)|CPIX - Rentabilitas dodolan miturut bathi resik|Quantum BioPharma Corp - Margin dodolan resik|FGEN (fibrogen.com) - Rentabilitas dodolan resik|TELO (Telomir Pharmaceuticals) - Rentabilitas dodolan miturut bathi resik|Rani Therapeutics Holdings - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik SNYR|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma